![Dermala Awarded Grand Prize in Inaugural Colgate Connect Challenge](https://www.seventure.fr/wp-content/uploads/2020/07/10_104270789-322x211.jpg)
Dermala Awarded Grand Prize in Inaugural Colgate Connect Challenge
DERMALA, a consumer dermatology company that develops novel treatments for chronic skin conditions, announces the brand's Grand Prize recognition in the global pitch...
Search
Life Sciences
DERMALA, a consumer dermatology company that develops novel treatments for chronic skin conditions, announces the brand's Grand Prize recognition in the global pitch...
MDoloris Medical Systems, leader in the field of objective analgesia/nociception monitoring during anesthesia and in intensive care, and Mindray, a global leader in developing...
MDoloris Medical Systems, a leader in the field of objective pain monitoring during anesthesia, announces today the regulatory clearance and marketing approval of its HFVI...
MaaT Pharma S.A. ("MaaT Pharma" or the “Company“), a French clinical-stage biotech and a pioneer in the development of microbiome2-based ecosystem therapies dedicated to...
Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological disorders and diseases, today announced that the...
Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy candidates toward clinical proof-of-concept.
Belfast-based livestock monitoring technology company CattleEye announced today that it has closed a $2.5m seed investment round from a syndicate led by Techstart Ventures and...
Aquaculture data analytics disrupter Ecto has raised $7 million in financing led by the Rabo Food & Agri Innovation Fund and Aqua-Spark. New investor Seventure Partners also...
BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage microbiome company advancing novel natural and engineered phage cocktails that target...
Axial Therapeutics, a clinical-stage biopharmaceutical company dedicated to improving the lives of people with neurological diseases, today announced the completion of a $37.25...